These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6642069)

  • 1. Efficacy and tolerance of enteric-coated erythromycin base (Ery-Max) administered twice or four times daily in patients with acute bronchitis.
    Pekkanen PS; Josefsson K
    J Int Med Res; 1983; 11(5):285-8. PubMed ID: 6642069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute bronchitis-efficacy of erythromycin base (Ery-Max) administered twice or four times daily.
    Pekkanen PS
    Rhinology; 1983 Mar; 21(1):83-5. PubMed ID: 6857107
    [No Abstract]   [Full Text] [Related]  

  • 3. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two oral forms of erythromycin in the treatment of acute respiratory tract infections. A multicentre general practice study.
    Macklin J; Barden R; Coles S
    J Int Med Res; 1989; 17(3):287-94. PubMed ID: 2670633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin in acute pharyngitis: a comparison of efficacy and patient tolerance of two twice-daily preparations.
    Guthrie R
    Clin Ther; 1988; 10(5):530-5. PubMed ID: 2856596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance and efficacy of erythromycin stearate tablets versus enteric-coated erythromycin base capsules in the treatment of patients with acne vulgaris.
    Bleeker J
    J Int Med Res; 1983; 11(1):38-41. PubMed ID: 6219902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Busman TA; Norris S; Notario GF
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Double-blind clinical trial comparing 5 days of dirithromycin versus 7 days of diacetylmidecamycin in acute bronchitis and acute exacerbations of chronic bronchitis].
    Sacristán JA; Elviro J; García de Lomas J; Palomino-Nicás J; Sobradillo V; Sánchez Gascón F; Valencia A; Calbo F; Viejo JL; Zamarrón C; Coca E; Casado MA; García Pérez LE; Hernández JM
    Enferm Infecc Microbiol Clin; 1997; 15(7):357-60. PubMed ID: 9410047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base.
    Wuolijoki E; Flygare U; Hildén M; Hurme J; Järvinen H; Leskinen J; Pynnönen S; Riikonen A; Salomaa V; Seuri M
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():107-12. PubMed ID: 3391872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis.
    Dunlay J; Reinhardt R; Roi LD
    J Fam Pract; 1987 Aug; 25(2):137-41. PubMed ID: 3302093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.
    Clayton D; Leslie A
    J Int Med Res; 1981; 9(6):470-7. PubMed ID: 7319133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A; Longest KA; Senetar JE; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
    Yakatan GJ; Rasmussen CE; Feis PJ; Wallen S
    J Clin Pharmacol; 1985; 25(1):36-42. PubMed ID: 3871797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets.
    Hovi T; Josefsson K; Renkonen OV
    Eur J Clin Pharmacol; 1983; 25(2):271-3. PubMed ID: 6628511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of patient tolerance to enteric-coated vs nonenteric-coated erythromycin.
    Ellsworth AJ; Christensen DB; Volpone-McMahon MT
    J Fam Pract; 1990 Sep; 31(3):265-70. PubMed ID: 2202773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin in the treatment of acute bronchitis in a community practice.
    Brickfield FX; Carter WH; Johnson RE
    J Fam Pract; 1986 Aug; 23(2):119-22. PubMed ID: 3525736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice-a-day regimen of erythromycin base is effective in the treatment of acute streptococcal tonsillitis.
    Hovi T; Svahn T; Valtonen V
    Scand J Infect Dis; 1987; 19(6):661-6. PubMed ID: 3327149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of erythromycin in the treatment of acute bronchitis.
    King DE; Williams WC; Bishop L; Shechter A
    J Fam Pract; 1996 Jun; 42(6):601-5. PubMed ID: 8656171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption of erythromycin stearate and enteric-coated erythromycin base after a single oral dose immediately before breakfast.
    Schreiner A; Digranes A
    Infection; 1984; 12(5):345-8. PubMed ID: 6511088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of albuterol and erythromycin for the treatment of acute bronchitis.
    Hueston WJ
    J Fam Pract; 1991 Nov; 33(5):476-80. PubMed ID: 1940815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.